Pfizer and Astellas' XTANDI® Combo Proves Effective in Reducing Prostate Cancer Metastasis Risk by 58%: Phase 3 EMBARK Trial Results Revealed

Data from Phase 3 EMBARK trial to be presented as a plenary session during the 2023 American Urological Association Annual Meeting Res...

May 01, 2023 | Monday | News
Merck Approves all Agenda Items at Annual General Meeting

Merck, a leading science and technology company, held its 28th Annual General Meeting virtually today. All of the resolutions on the agenda were approved, ...

April 30, 2023 | Sunday | News
Tempest Reports Early Results of TPST-1120 Study in First-Line Liver Cancer

Tempest will host a conference call accompanied by a slide presentation at 8:30 a.m. ET on Friday, April 28th. To join the conference call via phone and pa...

April 28, 2023 | Friday | News
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings

The items on the agenda of the ordinary and extraordinary general shareholders' meetings include the proposed approval of a number of resolutions relating ...

April 26, 2023 | Wednesday | News
Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock Split

Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) today announced that its stockholders have approved Proposa...

April 21, 2023 | Friday | News
Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its res...

April 19, 2023 | Wednesday | News
Predictive Oncology Adjourns Special Meeting of Stockholders

Due to the lack of quorum, the Special Meeting was adjourned to allow additional time for the Company’s stockholders to vote on the proposal to appro...

April 18, 2023 | Tuesday | News
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023

To participate, call 833-470-1428 within the U.S. or +1 929-526-1599 outside the U.S., access code: 522530. A live webcast of the conference call will also...

April 13, 2023 | Thursday | News
Ocugen to Host Virtual Investor & Analyst Event on April 14, 2023

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell th...

April 12, 2023 | Wednesday | News
Sanofi withdraws and refills Premerger Notification under HSR Act, extends tender offer for Provention Bio.

As previously announced on March 24, 2023, Sanofi commenced a cash tender offer to purchase all outstanding shares of common stock of Provention Bio, Inc. ...

April 11, 2023 | Tuesday | News
Thermo Fisher Scientific to Host Investor Day

The format will feature presentations by members of Thermo Fisher Scientific’s senior management team and conclude with a Q&A session. You can a...

April 10, 2023 | Monday | News
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023

The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to th...

April 07, 2023 | Friday | News
Scilex Holding Company Announces Postponement of Annual Meeting of Stockholders

Scilex is postponing the Annual Meeting due to the previously announced substantial underreporting of more than 44 million shares of its common stock by br...

April 06, 2023 | Thursday | News
InflaRx's Gohibic (vilobelimab) receives FDA Emergency Use Authorization for critically ill COVID-19 patients

Vilobelimab is the first authorized drug to control complement factor C5a, a protein that plays an important and often harmful role in the body's immune ...

April 05, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close